Respiratorius is a research company. Today, the company is mainly focused on development of new drug candidates for the treatment of chronic obstructive pulmonary disease (COPD), asthma and cancer. Additionally, the company focuses on project development in the area of cardiovascular diseases. The company was formed in 1999 as a spin-off from Lund University. The company is based in Lund.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Christer Fåhraeus | 10,34 | 10,34 | 2022-03-31 |
| Avanza Pension | 7,78 | 7,78 | 2022-03-31 |
| Valcuria Holding AB | 5,27 | 5,27 | 2022-04-01 |
| Ben Hayes | 2,34 | 2,34 | 2022-03-31 |
| Hans Harvig | 1,95 | 1,95 | 2022-03-31 |
| Benny Bengtsson | 1,30 | 1,30 | 2022-03-31 |
| Hartmut Wiese | 0,99 | 0,99 | 2022-03-31 |
| Christian Müller | 0,94 | 0,94 | 2022-03-31 |
| Handelsbanken Liv Försäkring AB | 0,80 | 0,80 | 2022-03-31 |
| Hans Mandahl | 0,79 | 0,79 | 2022-03-31 |
2022-06-09 Årsstämma 2021